Serglycin in human cancers.
- Author:
Xin-Jian LI
1
;
Chao-Nan QIAN
Author Information
- Publication Type:Journal Article
- MeSH: Autocrine Communication; Glycosylation; Hematologic Neoplasms; metabolism; pathology; Humans; Hyaluronan Receptors; metabolism; Nasopharyngeal Neoplasms; metabolism; pathology; Neoplasm Metastasis; Paracrine Communication; Protein Binding; Proteoglycans; biosynthesis; physiology; secretion; RNA, Messenger; metabolism; Vesicular Transport Proteins; biosynthesis; physiology; secretion
- From:Chinese Journal of Cancer 2011;30(9):585-589
- CountryChina
- Language:English
- Abstract: Serglycin belongs to a family of small proteoglycans with Ser-Gly dipeptide repeats, and it is modified with different types of glycosaminoglycan side chains. Intracellular serglycin affects the retention and secretion of proteases, chemokines, or other cytokines by physically binding to these factors in secretory granules. Extracellular serglycin has been found to be released by several types of human cancer cells, and it is able to promote the metastasis of nasopharyngeal carcinoma cells. Serglycin can bind to CD44, which is another glycoprotein located in cellular membrane. Serglycin's function of promoting cancer cell metastasis depends on glycosylation of its core protein, which can be achieved by autocrine as well as paracrine secretion mechanisms. Further investigations are warranted to elucidate serglycin signaling mechanisms with the goal of targeting them to prevent cancer cell metastasis.
